Randy Slemmon
Impact in
- Psychiatry and Mental health top 5%
- Dementia and Cognitive Impairment Research
- Physiology top 5%
- Alzheimer's disease research and treatments
Papers in
-
- Alzheimer's disease research and treatments 8
-
- Dementia and Cognitive Impairment Research 2
- Co-authors
- Hartmuth Christian Kolb (5 shared papers)Gallen Triana‐Baltzer (5 shared papers)Clara Theunis (3 shared papers)Marc H. Mercken (3 shared papers)Niklas Mattsson (1 shared paper)David Charles Airey (1 shared paper)Xiyun Chai (1 shared paper)Jeff L. Dage (1 shared paper)
- Journals
- Alzheimer s & Dementia (6 papers)Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring (2 papers)Clinical Pharmacokinetics (1 paper)Journal of Alzheimer s Disease (1 paper)Clinical Therapeutics (1 paper)
- Partner nations
- United StatesGermanyBelgium
In The Last Decade
Randy Slemmon
14 papers receiving 570 citations
Randy Slemmon's Hit Papers
Peers
Comparison fields: 5 of 64
- Psychiatry and Mental health 213
- Physiology 366
- Neurology 89
- Biological Psychiatry 19
- Pharmacology 93
Countries citing papers authored by Randy Slemmon
This map shows the geographic impact of Randy Slemmon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Randy Slemmon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Randy Slemmon more than expected).
Fields of papers citing papers by Randy Slemmon
This network shows the impact of papers produced by Randy Slemmon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Randy Slemmon. The network helps show where Randy Slemmon may publish in the future.
Co-authors
The 25 scholars most cited alongside Randy Slemmon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer’s disease Hit paper breakdown → | 2020 | 324 |
| 2 | 2012 | 58 | |
| 3 | 2022 | 43 | |
| 4 | 2012 | 39 | |
| 5 | 2021 | 31 | |
| 6 | 2012 | 29 | |
| 7 | 2020 | 20 | |
| 8 | 2012 | 14 | |
| 9 | 2010 | 8 | |
| 10 | 2010 | 6 | |
| 11 | 2011 | 3 | |
| 12 | 2022 | 3 | |
| 13 | 2010 | 2 | |
| 14 | 2010 | 1 | |
| 15 | 2011 | 0 |
About Randy Slemmon
Randy Slemmon is a scholar working on Physiology, Psychiatry and Mental health, Pharmacology, Biological Psychiatry and Pharmacology, having authored 15 papers that have together received 581 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (8 papers), Dementia and Cognitive Impairment Research (2 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Statistical Methods in Clinical Trials (1 paper), Computational Drug Discovery Methods (1 paper), Tryptophan and brain disorders (1 paper), Pharmacogenetics and Drug Metabolism (1 paper) and Cancer Treatment and Pharmacology (1 paper). The work is most often cited by research in Psychiatry and Mental health (213 citations), Physiology (366 citations), Neurology (89 citations), Biological Psychiatry (19 citations) and Pharmacology (93 citations). Randy Slemmon has collaborated with scholars based in United States, Germany and Belgium. Frequent co-authors include Hartmuth Christian Kolb, Gallen Triana‐Baltzer, Clara Theunis, Marc H. Mercken, Niklas Mattsson, David Charles Airey, Xiyun Chai, Jeff L. Dage, Nicholas Kyle Proctor and Oskar Hansson. Their work appears in journals such as Alzheimer s & Dementia, Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring, Clinical Pharmacokinetics, Journal of Alzheimer s Disease and Clinical Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.